Diagnosis and management of thalassaemia

No abstract is available for this paper.

• Publication year

  2012

• Venue

  British medical journal

• Publication date

  2012-01-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bmj.e228PMID 22277544
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral deferiprone for iron chelation in people with thalassaemia.

  2013cited by this paper
• Endocrine complications in patients with thalassaemia major

  2013cited by this paper
• Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.

  2013cited by this paper
• Improvement in liver pathology of patients with β-thalassemia treated with deferasirox for at least 3 years.

  2011cited by this paper
• Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload

  2011cited by this paper
• Heterogeneity of hemoglobin H disease in childhood.

  2011cited by this paper
• Optimal management of β thalassaemia intermedia

  2011cited by this paper
• Iron-chelating therapy for transfusional iron overload.

  2011cited by this paper
• Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up.

  2011cited by this paper
• Iron-chelating therapy for transfusional iron overload.

  2011cited by this paper
• Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study.

  2010cited by this paper
• Liver iron concentration quantification by MRI: are recommended protocols accurate enough for clinical practice?

  2010cited by this paper
• Combined iron chelation therapy

  2010cited by this paper
• Significant haemoglobinopathies: guidelines for screening and diagnosis

  2010cited by this paper
• HbE/β-thalassemia: basis of marked clinical diversity.

  2010cited by this paper
• Hematopoietic stem cell transplantation for hemoglobinopathies: current practice and emerging trends.

  2010cited by this paper
• Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major

  2010cited by this paper
• Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major

  2009cited by this paper
• Alpha thalassemia major--new mutations, intrauterine management, and outcomes.

  2009cited by this paper
• Guidelines for the Clinical Management of Thalassaemia

  2008cited by this paper
• The Molecular Pathology of the Thalassaemias

  2008cited by this paper
• Long‐term results of survival in patients with thalassemia major treated with bone marrow transplantation

  2008cited by this paper
• MID1 mutation screening in a large cohort of Opitz G/BBB syndrome patients: twenty‐nine novel mutations identified

  2007cited by this paper
• HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update

  2007cited by this paper
• Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.

  2006cited by this paper
• Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.

  2005cited by this paper
• Unrelated Bone Marrow Transplantation for β‐Thalassemia Patients: The Experience of the Italian Bone Marrow Transplant Group

  2005cited by this paper
• Survival and Complications in Thalassemia

  2005cited by this paper
• Changes in the Epidemiology of Thalassemia in North America: A New Minority Disease

  2005cited by this paper
• Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia.

  2004cited by this paper
• Carrier screening and genetic counselling in β-thalassemia

  2002cited by this paper
• Carrier screening and genetic counselling in beta-thalassemia.

  2002cited by this paper
• Hb H hydrops foetalis syndrome: a case report and review of literature

  2001cited by this paper
• Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.

  2001cited by this paper
• Hepatic iron concentration and total body iron stores in thalassemia major.

  2000cited by this paper
• Hepatic iron concentration and total body iron stores in thalassemia major.

  2000cited by this paper
• Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia Register

  2000cited by this paper
• The population genetics of the haemoglobinopathies.

  1998cited by this paper
• Thalassaemia and malaria, revisited.

  1997cited by this paper
• Iron-chelation therapy with oral deferiprone in patients with thalassemia major.

  1995cited by this paper
• Survival in Medically Treated Patients with Homozygous β-Thalassemia

  1994cited by this paper
• Survival in medically treated patients with homozygous beta-thalassemia.

  1994cited by this paper
• The population genetics of the haemoglobinopathies.

  1993cited by this paper

• Revolutionizing Thalassaemia Detection: The Emerging Role of Artificial Intelligence and Machine Learning

  2026cites this paper
• Red Blood Cell Disorders in Newborns: Bridging Traditional and Modern Diagnostics

  2025cites this paper
• Thalassemia in Bangladesh: progress, challenges, and a strategic blueprint for prevention

  2025cites this paper
• Arrhythmias During Pregnancy: Ventricular Tachycardia in the Setting of Maternal Beta Thalassemia Minor

  2024cites this paper
• Levels of IL-18 and IL-28 in thalassemia patients with viral infections

  2024cites this paper
• β-Thalassemia Major Complicated by Acute Myeloid Leukemia

  2024cites this paper
• Thalassemia carrier status and groundwater iron: Implication for iron supplementation program for children in Bangladesh

  2023cites this paper
• Case Report of a Child with Beta Thalassemia Major in a Tribal Region of India

  2023cites this paper
• Thalassemia and hemoglobinopathy prevalence in a community-based sample in Sylhet, Bangladesh

  2023cites this paper
• β-thalassemia intermedia with autoimmune hemolytic anemia and multiple cholelithiasis complications

  2023cites this paper
• Plasma proteome profiling combined with clinical and genetic features reveals the pathophysiological characteristics of β-thalassemia

  2022cites this paper
• A Case of Anaemia With High-Grade Splenomegaly

  2022cites this paper
• The scenario of knowledge, attitude and practice of the Bangladeshi population towards thalassemia prevention: A nationwide study

  2022cites this paper
• Public Perceptions and Attitudes of Bangladeshi Population towards Thalassemia Prevention: A Nationwide Study

  2021cites this paper
• Public Perceptions and Attitudes of Bangladeshi Population towards Thalassemia Prevention: A Nationwide Study

  2021cites this paper
• Anemia and PET imaging

  2021cites this paper
• Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.

  2021cites this paper
• Living with thalassaemia in Papua New Guinea, the experience of children, adolescents and their families

  2021cites this paper
• Alpha‐thalassemia. Case report alpha‐thalassemia in a Costa Rican family, A case report

  2020cites this paper
• Stochastic bond dynamics facilitates alignment of malaria parasite at erythrocyte membrane upon invasion

  2020cites this paper
• Classification of thalassemia data using random forest algorithm

  2020cites this paper
• Microcytic Anemia: A Brief Overview

  2020cites this paper
• Hyperparameter Optimization on Support Vector Machine using Grid Search for Classifying Thalassemia Data

  2020cites this paper
• Growth hormone therapy for people with thalassaemia.

  2020cites this paper
• Importance of erythrocyte deformability for the alignment of malaria parasite upon invasion

  2019cites this paper
• Multiple displacement amplification as the first step can increase the diagnostic efficiency of preimplantation genetic testing for monogenic disease for β‐thalassemia

  2019cites this paper
• 14-month old boy with abrupt-onset petechiae and bruising

  2019cites this paper
• A web-based educational intervention module to improve knowledge and attitudes towards thalassaemia prevention in Malaysian young adults.

  2019cites this paper
• The Incidence of Minor β-thalassemia Among Individuals Participated in Premarital Screening Program in Ardabil Province: North-west of Iran

  2019cites this paper
• Anemia infantil

  2019cites this paper
• A Case Report and Review of the Literature

  2018influential citation
• The role of red cell distribution width in the differential diagnosis of iron deficiency anemia and non-transfusiondependent thalassemia patients

  2018cites this paper
• Awareness about thalassemia in post graduate students

  2018cites this paper
• Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.

  2018cites this paper
• Risk for red cell immunization among thalassemic patients

  2017cites this paper
• Deferasirox for managing iron overload in people with thalassaemia.

  2017cites this paper
• Iron overload in beta thalassemia major patients

  2017cites this paper
• Growth hormone therapy for people with thalassaemia.

  2017cites this paper
• Estimation of co-integration of the relationship between blood transfusion and iron deposits in thalassemia patients and study of the effects of some physiological factors

  2016cites this paper
• Patient Involvement as Experts in the Development and Assessment of a Smartphone App as a Patient Education Tool for the Management of Thalassemia and Iron Overload Syndromes

  2016cites this paper
• Efficacy of Deferasirox (Exjade®) versus Osveral® in Treatment of Iron Overload in Patients with Beta- thalassemia Major in Iran; A Non-randomized Controlled Trial

  2016cites this paper
• Investigation of P-Wave Dispersion in Adult Patients with Beta-Thalassemia Major

  2016cites this paper
• Emerging cellular and gene therapies for congenital anemias

  2016cites this paper
• Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.

  2015cites this paper
• Metabolically programmed iron chelators.

  2015cites this paper
• Effects of α-thalassaemia mutations on the haematological parameters of β-thalassaemia carriers

  2015cites this paper
• Evaluation of Some Humoral Immune System Parameters in Beta Thalassemia Major Patients at Wasit Province / Iraq

  2015cites this paper
• Successful Outcomes of Pediatric Hematopoietic Cell Transplantations for Thalassemia and Sickle Cell Diseases

  2014cites this paper
• The Free Alpha-Hemoglobin: A Promising Biomarker for β-Thalassemia

  2014cites this paper
• Hematology in Clinical Pathology

  2014cites this paper
• Desferrithiocin: A Search for Clinically Effective Iron Chelators

  2014cites this paper
• Hemoglobin E disorder: Newborn screening program

  2013cites this paper
• Heterogeneity of myocardial iron distribution in response to chelation therapy in patients with transfusion-dependent anemias

  2013cites this paper
• Analysis of β/α Globin Ratio by Using Relative qRT‐PCR for Diagnosis of Beta‐Thalassemia Carriers

  2013cites this paper
• Iron regulation by hepcidin.

  2013cites this paper
• Comparative study of hypogonadism in beta-thalassemia intermedia patients with and without hydroxyurea

  2012cites this paper
• Red cell alloimmunization and autoantibodies in Egyptian transfusion-dependent thalassaemia patients

  2010cites this paper
• Discovery and function of hepcidin in iron homeostasis

  year unknowncites this paper
• Cardiopulmonary Bypass Graft in a Post COVI-19 Thalassemic Patient

  year unknowncites this paper